Found: 4
Select item for more details and to access through your institution.
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630589
- By:
- Publication type:
- Article
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 5, p. 1, doi. 10.1007/s11912-021-01042-w
- By:
- Publication type:
- Article
Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (<sup>177</sup>Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 477, doi. 10.1634/theoncologist.2020-0028
- By:
- Publication type:
- Article
Imaging expression of prostate‐specific membrane antigen and response to PSMA‐targeted β‐emitting radionuclide therapies in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 5, p. 279, doi. 10.1002/pros.24104
- By:
- Publication type:
- Article